Merger Pending

Treeline Biosciences and Standard BioTools merger

US$460m equity value

Announced 8 Jun 2026 · NASDAQ: LAB

Advisers

Standard BioTools

Target

Financial adviser
Legal adviser

Acquirer

Financial adviser
Target
Standard BioTools
Target based in
United States
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.